These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 29976244)

  • 1. Activities of stromal and immune cells in HPV-related cancers.
    Barros MR; de Melo CML; Barros MLCMGR; de Cássia Pereira de Lima R; de Freitas AC; Venuti A
    J Exp Clin Cancer Res; 2018 Jul; 37(1):137. PubMed ID: 29976244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune cells in the tumor microenvironment.
    Li MO; Wolf N; Raulet DH; Akkari L; Pittet MJ; Rodriguez PC; Kaplan RN; Munitz A; Zhang Z; Cheng S; Bhardwaj N
    Cancer Cell; 2021 Jun; 39(6):725-729. PubMed ID: 34129817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hrHPV E5 oncoprotein: immune evasion and related immunotherapies.
    de Freitas AC; de Oliveira THA; Barros MR; Venuti A
    J Exp Clin Cancer Res; 2017 May; 36(1):71. PubMed ID: 28545552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
    Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
    Front Immunol; 2018; 9():1288. PubMed ID: 29915603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
    Barros MR; de Oliveira THA; de Melo CML; Venuti A; de Freitas AC
    J Immunol Res; 2018; 2018():2912671. PubMed ID: 29854832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy.
    Wennerberg E; Lundqvist A; Mao Y; Mougiakakos D
    Front Immunol; 2021; 12():718844. PubMed ID: 34276709
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.
    Zalfa C; Paust S
    Front Immunol; 2021; 12():633205. PubMed ID: 34025641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against HPV-16-Associated Tumors Requires the Activation of CD8+ Effector Memory T Cells and the Control of Myeloid-Derived Suppressor Cells.
    Diniz MO; Sales NS; Silva JR; Ferreira LC
    Mol Cancer Ther; 2016 Aug; 15(8):1920-30. PubMed ID: 27222537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity.
    Tumino N; Besi F; Martini S; Di Pace AL; Munari E; Quatrini L; Pelosi A; Fiore PF; Fiscon G; Paci P; Scordamaglia F; Covesnon MG; Bogina G; Mingari MC; Moretta L; Vacca P
    Front Immunol; 2021; 12():803014. PubMed ID: 35116033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis.
    Glover A; Zhang Z; Shannon-Lowe C
    Front Immunol; 2023; 14():1161848. PubMed ID: 37033972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.
    Xing Y; Ruan G; Ni H; Qin H; Chen S; Gu X; Shang J; Zhou Y; Tao X; Zheng L
    Front Immunol; 2021; 12():624725. PubMed ID: 34084160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
    De Cicco P; Ercolano G; Ianaro A
    Front Immunol; 2020; 11():1680. PubMed ID: 32849585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.
    Raikhy G; Woodby BL; Scott ML; Shin G; Myers JE; Scott RS; Bodily JM
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
    Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
    mBio; 2016 May; 7(3):. PubMed ID: 27143385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
    Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
    Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.
    Joshi S; Sharabi A
    Pharmacol Ther; 2022 Jul; 235():108114. PubMed ID: 35122833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment.
    Haas L; Obenauf AC
    Front Immunol; 2019; 10():2746. PubMed ID: 31849950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.
    Amador-Molina A; Hernández-Valencia JF; Lamoyi E; Contreras-Paredes A; Lizano M
    Viruses; 2013 Oct; 5(11):2624-42. PubMed ID: 24169630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine.
    Yaseen MM; Abuharfeil NM; Darmani H; Daoud A
    Open Biol; 2020 Sep; 10(9):200111. PubMed ID: 32931721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine Cathepsins in Tumor-Associated Immune Cells.
    Jakoš T; Pišlar A; Jewett A; Kos J
    Front Immunol; 2019; 10():2037. PubMed ID: 31555270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.